Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications

Bioconjugate Chemistry

Volumn 10, Issue 5, 1999, Pages 867-876

  Foulon, Catherine F ^a   Bigner, Darell D ^a   Zalutsky, Michael R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FLUIDS; CARBOXYLATION; COENZYMES; MAMMALS; SURFACE PLASMON RESONANCE; TUMORS;

'CURRENT; 2-IMINOTHIOLANE; BINDING CAPACITIES; BIOTIN BINDING; EXTRACELLULAR MATRIX PROTEIN; HUMANS MICE; IMMUNOREACTIVITIES; STREPTAVIDIN; TENASCIN; THERAPEUTIC POTENTIALS;

MONOCLONAL ANTIBODIES;

EID: 0033200303     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc990040w     Document Type: Article

References (35)

1. Goldenberg, D. M. (1994) New developments in monoclonal antibodies for cancer detection and therapy. CA Cancer J. 44, 43-64.
2. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigation of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294-1302.
3. Paganelli, G., Magnani, P., Zito F., Villa, E., Sudati, F., Lopalco, L., Rossetti, C., Malcovati, M., Chiolerio, F., Seccamani, E., Siccardi, A. G., and Fazio, F. (1991) Three-step monoclonal antibody tumor targeting in carcinoembryonic antigen-positive patients. Cancer Res. 51, 5960-5966.
4. Stoldt, H. S., Aftab, F., Chinol, M., Paganelli, G., Luca, F., Testori, A., and Geraghty, J. G. (1997) Pretargeting strategies for radio-immunoguided tumour localization and therapy. Eur. J. Cancer 33, 186-192.
5. Sung, C. and van Osdol, W. (1995) Pharmacokinetic comparison of direct antibody targeting with pretargeting protocols based on streptavidin-biotin binding. J. Nucl. Med. 36, 867-876.
6. Breitz, H., Knox, S., Weiden, P., Goris, M., Murtha, A., Bryan, J., Axworthy, D., Seiler, C., Su, F.-M., Beaumier, and P., Reno, J. (1998) Pretargeted radioimmunotherapy with antibody-streptavidin and Y-90 DOTA-biotin (Avicidin): result of a dose escalation study. J. Nucl. Med. 39, 71P (abstr.).
7. 90Y-biotin. J. Nucl. Med. 39, 70P (abstr.).
8. Bourdon, M. A., Wikstrand, C. J., Furthmayr, H., Matthews, T. J., and Bigner, D. D. (1983) Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody. Cancer Res. 43, 2796-2805.
9. Howeedy, A. A., Virtanen, I., Laitinen, L., Gould, N. S., Koukoulis, G. K., and Gould, V. E. (1990) Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab. Invest. 63, 798-806.
10. Mackie, E. J., Chiquet-Ehrismann, R., Pearson, C. A., Inaguma, Y., Taya, K., Kawarada, Y., and Sakakura, T. (1987) Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc. Natl. Acad. Sci. U.S.A. 84, 4621-4625.
11. 131I-labeled anti-tenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasm or primary brain tumor resection cavities with subarachnoid communication: Phase I trial results. Clin. Cancer Res. 2, 963-972.
12. Bigner, D. D., Brown, M. T., Friedman, A. H., Coleman, R. E., Akabani, G., Friedman, H. S., Thorstad, W. L., McLendon, R. E., Bigner, S. H., Zhao, X.-G., Pegram, C. N., Wikstrand, C. J., Herndon, J. E., II, Vick, N. A., Paleologos, N., Cokgor, I., and Zalutsky, M. R. (1998) Iodine-131-labeled anti-tenascin monoclonal antidoby 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results. J. Clin. Oncol. 16, 2202-2212.
13. Foulon, C. F., Alston, K. L., and Zalutsky, M. R. (1997) Synthesis and preliminary evaluation of (3-iodobenzoyl)-norbiotinamide and (5-iodo-3-pyridine)carbonyl norbiotinanude: Two radioiodinated conjugates with improved stability. Bioconjugate Chem. 8, 179-186.
14. Foulon, C. F., Alston, K. L., and Zalutsky, M. R. (1998) Astatine-211 labeled biotin conjugates resistant to biotinidase for use in pretargeted radioimmunotherapy. Nucl. Med. Biol. 25, 81-88.
15. Murphy-Ullrich, J. E., Lightner, V. A., Aukhil, I., Yan, Y. Z., Erickson, H. P., and Höök, M. (1991) Focal adhesion interity is downregulated by the alternatively spliced domain of human tenascin. J. Cell Biol. 115, 1127-1136.
16. He, X., Archer, G. E., Wikstrand, C. J., Morrison, S. L., Zalutsky, M. R., Bigner, D. D., and Batra, S. K. (1994) Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin. J. Neuroimmunol. 52, 127-137.
17. Zalutsky, M. R., Schuster, J. M., Garg, P. K., Archer, Jr., G. E., Dewhirst, M. W., and Bigner, D. D. (1996) Two approaches for enhancing radioimmunotherapy: alpha emitters and hyperthermia. Recent Results Cancer Res. 141, 101-122.
18. Foulon, C. F., Adelstein, S. J., and Kassis, A. I. (1996) One-step synthesis of radiolabeled biotin derivatives. Bioorg. Med. Chem. Let. 6, 779-784.
19. Lindmo, T., Boven, E., Cuttitta, F., Fedoroko, J., and Bunn, P. A., Jr. (1984) Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods 72, 77-89.
20. Bullard, D. E., Schold, S. C., Jr., Bigner, S. H., and Bigner, D. D. (1981) Growth and chemotherapeutic response in athymic mice of tumors arising from human glioma-derived cell lines. J. Neuropathol. Exp. Neurol. 40, 410-427.
21. 211At]astatoanilide. Nucl. Med. Biol. 24, 135-143.
22. Kassis, A. I., Jones, P. L., Matalka, K. Z., and Adelsein, S. J. (1996) Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin. J. Nucl. Med. 37, 343-352.
23. Chinol, M., Casalini, P., Maggiolo, M., Canervari, S. Omodeo, E. S., Caliceti, P., Veronese, F. M., Cremonesi, M., Chiolerio, F., Nardone, E., Siccardi, A. G., and Paganelli, G. (1998) Biochemical modifications of avidin improve pharamacokinetics and biodistribution, and reduce immunogenicity. Br. J. Cancer 78, 189-197.
24. Khawli, L. A., Alauddin, M. M., Miller, G. K., and Epstein, A. L. (1993) Improved immunotargeting of tumors with biotinylated monoclonal antibodies and radiolabeled streptavidin. Antibody, Immunoconjugates, Radiopharm. 6, 13-27.
25. Ngai, W. M., Reilly, R. M., Polihronis, J., and Shpitz, B. (1995) In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49. Nucl. Med. Biol. 22, 77-86.
26. 111In]biocytin to cultured ovarian adenocarcinoma cells using covalent monoclonal antibody-streptavidin conjugates. Appl. Radiat. Isot. 43, 1399-1402.
27. Karacay, H., Sharkey, R. M., Govindan, S. V., McBride, W. J., Goldenberg, D. M., Hansen, H. J., and Griffiths, G. L. (1997) Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development. Bioconjugate Chem. 8, 585-594.
28. Reno, J. M., Theodore, L. J., and Gustavson, L. M. (1997) Two-step pretargeting methods using improved biotin-active agent conjugates. U.S. Patent 5,630,996.
29. Del Rosario, R. B., Baron, L.-A., Lawton, R. G., and Wahl, R. L. (1992) Streptavidin-biotinylated IgG conjugates: a simple procedure for reducing polymer formation. Nucl. Med. Biol. 19, 417-421.
30. Wilbur, D. S., Hamlin, D. K., Vessella, R. L., Stray, J. E., Buhler, K. R., Stayton, P. S., Klumb, L. A., Pathare, P. M., and Weerawarna, S. A. (1996) Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab, colocalization with recombinant streptavidin and avidin. Bioconjugate Chem. 7, 689-702.
31. 111In-DTPA-biocytin. Nucl. Med. Biol. 23, 459-466.
32. Del Rosario, R. B., and Wahl, R. L. (1989) Site-specific radiolabeling of monoclonal antibodies with biotin/streptavidin. Nucl. Med. Biol. 16, 525, 529.
33. Reist, C. J., Bigner, D. D., and Zalutsky, M. R. (1998) Human IgG2 constant region enhances in vivo stability of anti-tenascin antibody 81C6 compared with its murin parent. Clin. Cancer Res. 4, 2495-2502.
34. 131I-labeled anti-tenascin monoclonal antibody 81C6 in patients with gliomas and other intracranial malignancies. Cancer Res. 49, 2807-2813.
35. Wolf, B., Hymes, J., and Heard, G. S. (1990) Biotinidase. Methods Enzymol. 184, 103-111.